You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Effectuez un dépistage du virus de l'hépatite B chez tous les patients cancéreux débutant un traitement systémique. Apprenez-en davantage sur le dépistage et la gestion du virus de l'hépatite B.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Que contient le nouveau formulaire de médicaments

Vous trouverez ici toutes les monographies de médicaments et de régimes nouvelles et récemment mises à jour, ainsi que les fiches de renseignements sur les patients et les documents de sécurité et de conseils.

Drug

Published Date: 28 Mar 2024

Revision Summary:
Drug Monograph: Updated Adverse effects section
Patient Info Sheet EN: Updated/Revised information sheet
Patient Info Sheet FR: New information sheet (Nouvelle fiche d'information)
Updated
Mar 2024
Regimen
Published Date: 28 Mar 2024
Cancer Type:
Hematologic, 
Multiple Myeloma
Intent: Palliative
Revision Summary:

Regimen Monograph: Expanded into full regimen monograph

Updated
Mar 2024
Drug

Published Date: 28 Mar 2024

Revision Summary:
Drug Monograph: Updated Supplementary public funding section
Updated
Mar 2024
Regimen
Published Date: 27 Mar 2024
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/uses and Dose modifications sections; added funding information

Updated
Mar 2024
Regimen
Published Date: 27 Mar 2024
Cancer Type:
Lung, 
Non-Small Cell
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Drug

Published Date: 27 Mar 2024

Revision Summary:
Drug Monograph: Updated Dose modifications and Supplementary public funding sections
Patient Info Sheet EN: Updated “How will this medication affect sex, pregnancy and breastfeeding?“ section
Patient Info Sheet FR: Updated “How will this medication affect sex, pregnancy and breastfeeding?“ section (Mise à jour de la section « Comment ce médicament affecte-il les relations sexuelles, la grossesse et l’allaitement?»)
Updated
Mar 2024
Regimen
Published Date: 27 Mar 2024
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Dose modifications section

Updated
Mar 2024
Regimen
Published Date: 27 Mar 2024
Cancer Type:
Lung, 
Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Regimen
Published Date: 27 Mar 2024
Cancer Type:
Lung, 
Non-Small Cell
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Regimen
Published Date: 27 Mar 2024
Cancer Type:
Genitourinary, 
Bladder / Urothelial
Intent: Palliative
Revision Summary:

Regimen Monograph: Modified Dosage in hepatic impairment, Adverse effects, Drug administration, Pregnancy/lactation and Monitoring sections

Updated
Mar 2024
Drug

Published Date: 27 Mar 2024

Revision Summary:
Drug Monograph: Modified Indications, Dosage in hepatic impairment, Administration guidelines and Special precautions, and Monitoring sections
Patient Info Sheet EN: Updated/revised information sheet
Patient Info Sheet FR: Updated/revised information sheet (Fiche d’information mise à jour/révisée)
Updated
Mar 2024
Regimen
Published Date: 26 Mar 2024
Cancer Type:
Genitourinary, 
Prostate
Intent: Palliative
Revision Summary:

Regimen Monograph: Added darolutamide funding information

Updated
Mar 2024

Pages